Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.

Bleckmann A, Siam L, Klemm F, Rietkötter E, Wegner C, Kramer F, Beissbarth T, Binder C, Stadelmann C, Pukrop T.

Clin Exp Metastasis. 2013 Apr;30(4):471-82. doi: 10.1007/s10585-012-9552-7. Epub 2012 Dec 8.

2.

ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.

PMID:
24846398
3.

LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer.

Kriegl L, Horst D, Reiche JA, Engel J, Kirchner T, Jung A.

J Transl Med. 2010 Nov 22;8:123. doi: 10.1186/1479-5876-8-123.

4.

Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.

Eichhoff OM, Weeraratna A, Zipser MC, Denat L, Widmer DS, Xu M, Kriegl L, Kirchner T, Larue L, Dummer R, Hoek KS.

Pigment Cell Melanoma Res. 2011 Aug;24(4):631-42. doi: 10.1111/j.1755-148X.2011.00871.x. Epub 2011 Jun 9.

PMID:
21599871
5.

Wnt signaling in triple negative breast cancer is associated with metastasis.

Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C, Kerstann KF, Sledge GW Jr, Abramovitz M, Bouzyk M, De P, Leyland-Jones BR.

BMC Cancer. 2013 Nov 10;13:537. doi: 10.1186/1471-2407-13-537.

6.

Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.

Chen XY, Wang ZC, Li H, Cheng XX, Sun Y, Wang XW, Wu ML, Liu J.

Hum Pathol. 2005 Dec;36(12):1294-301. Epub 2005 Oct 28.

PMID:
16311123
7.
8.

Expression of canonical WNT/β-CATENIN signaling components in the developing human lung.

Zhang M, Shi J, Huang Y, Lai L.

BMC Dev Biol. 2012 Jul 30;12:21. doi: 10.1186/1471-213X-12-21.

9.

ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.

Wu L, Zhao JC, Kim J, Jin HJ, Wang CY, Yu J.

Cancer Res. 2013 Oct 1;73(19):6068-79. doi: 10.1158/0008-5472.CAN-13-0882. Epub 2013 Aug 1.

10.

Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.

Zhang JX, Zhang J, Yan W, Wang YY, Han L, Yue X, Liu N, You YP, Jiang T, Pu PY, Kang CS.

Neuro Oncol. 2013 Mar;15(3):279-89. doi: 10.1093/neuonc/nos306. Epub 2013 Jan 7.

11.

WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.

Denysenko T, Annovazzi L, Cassoni P, Melcarne A, Mellai M, Schiffer D.

Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):31-45.

PMID:
26708597
12.

DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.

Guturi KK, Sarkar M, Bhowmik A, Das N, Ghosh MK.

Breast Cancer Res. 2014 Dec 12;16(6):496. doi: 10.1186/s13058-014-0496-5.

13.

The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis.

Mahmoudi T, Boj SF, Hatzis P, Li VS, Taouatas N, Vries RG, Teunissen H, Begthel H, Korving J, Mohammed S, Heck AJ, Clevers H.

PLoS Biol. 2010 Nov 16;8(11):e1000539. doi: 10.1371/journal.pbio.1000539. Erratum in: PLoS Biol. 2017 Feb 7;15(2):e1002596.

14.

Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.

Zhang XW, Chen SY, Xue DW, Xu HH, Yang LH, Xu HT, Wang EH.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15086-92. eCollection 2015.

15.

Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.

Li X, Pu J, Jiang S, Su J, Kong L, Mao B, Sun H, Li Y.

PLoS One. 2013 Jul 2;8(7):e68525. doi: 10.1371/journal.pone.0068525. Print 2013.

16.

Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.

Fotopoulos G, Gousia A, Bareta E, Koumpis E, Chrisafi S, Bobos M, Malamou-Mitsi V, Fountzilas G, Pavlidis N, Pentheroudakis G.

Eur J Clin Invest. 2015 Nov;45(11):1145-52. doi: 10.1111/eci.12518. Epub 2015 Sep 13.

PMID:
26269154
17.

β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.

Sánchez-Tilló E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A.

Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19204-9. doi: 10.1073/pnas.1108977108. Epub 2011 Nov 11.

18.

Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.

Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.

Oncogene. 2012 May 31;31(22):2750-60. doi: 10.1038/onc.2011.453. Epub 2011 Oct 3.

PMID:
21963845
19.

Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade.

Cha N, Liu W, Yang N, Xie S, Gao Y, Chen X, Wang X, Ren J.

Tumour Biol. 2014 Oct;35(10):10319-24. doi: 10.1007/s13277-014-2210-8. Epub 2014 Jul 19.

PMID:
25034524
20.

CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.

Zhang Y, Liu C, Duan X, Ren F, Li S, Jin Z, Wang Y, Feng Y, Liu Z, Chang Z.

J Biol Chem. 2014 Aug 15;289(33):22589-99. doi: 10.1074/jbc.M114.560979. Epub 2014 Jun 30.

Supplemental Content

Support Center